Table of Contents
Assessing Drug Transfer into Breast Milk
Four discussion points
1. Why do we need data?
PPT Slide
PPT Slide
“No hard data” leads to formula-feeding by default
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
“TDM” drug
Identifying contraindicated drug
2. What data do we need?
Exposure Index
3. Carrier-mediated systems
PPT Slide
Organic cation transporters
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
4. Graded approach
“Level 0” Preclinical Study
“Level I” Clinical Study
“Level II” Clinical Study
|